The FDA has signed off on the emergency use of Abiomed’s (NASDAQ:ABMD)
Impella RP heart pump for the treatment of hospitalized patients with
COVID-19-related right heart failure or decomposition, including
pulmonary embolism.
https://seekingalpha.com/news/3578916-fda-oks-emergency-use-abiomed-heart-pump-for-covidminus-19-related-heart-failure
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.